Dr. Elmacken is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Michigan Ave NW
Washington, DC 20010Phone+1 718-334-3380
Education & Training
Westchester Medical CenterFellowship, Pediatric Hematology/Oncology, 2012 - 2015
University of Alexandria Faculty of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 2012 - 2026
MD State Medical License 2017 - 2026
NY State Medical License 2012 - 2024
MI State Medical License 2018 - 2022
DC State Medical License 2015 - 2018
NH State Medical License 2012 - 2014- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- FDA Approval Summary: Lisocabtagene Maraleucel for Second-Line Treatment of Large B-Cell Lymphoma.Mona Elmacken, Helkha Peredo-Pinto, Cong Wang, Zhenzhen Xu, Million Tegenge
Clinical Cancer Research. 2024-06-03 - 68 citationsObinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody-dependent cytotoxicity and improves overall survival against CD20(+) rituxima...Aradhana Awasthi, Janet Ayello, Carmella van de Ven, Mona Elmacken, Anthony Sabulski
British Journal of Haematology. 2015-10-16
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
